STRO

37.32

2.79% -1.07

Vorhandelsmarkt: 37.75 0.43 +1.15%

Sutro Biopharma Inc (STRO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$38.39

Offen:

$38.59

24-Stunden-Volumen:

236.50K

Relative Volume:

1.18

Marktkapitalisierung:

$618.31M

Einnahmen:

$102.48M

Nettoeinkommen (Verlust:

$-191.09M

KGV:

-2.588

EPS:

-14.4203

Netto-Cashflow:

$-178.93M

1W Leistung:

+7.58%

1M Leistung:

+56.94%

6M Leistung:

+279.23%

1J Leistung:

+255.43%

1-Tages-Spanne:

$36.31

$39.74

1-Wochen-Bereich:

$31.76

$39.74

52-Wochen-Spanne:

$6.736

$39.74

Sutro Biopharma Inc Stock (STRO) Company Profile

Firmenname

Sutro Biopharma Inc

Sektor

Healthcare (1106)

Branche

Biotechnology (615)

Telefon

650-392-8412

Adresse

111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA

Mitarbeiter

137

Twitter

@SutroBio

Nächster Verdiensttermin

2026-05-14

Neueste SEC-Einreichungen

STRO's Discussions on Twitter

Compare STRO vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
STRO Sutro Biopharma Inc	37.32	618.31M	102.48M	-191.09M	-178.93M	-14.42
VRTX Vertex Pharmaceuticals Inc	424.36	107.87B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	702.27	73.63B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	794.70	49.42B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	301.11	40.20B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	297.49	33.06B	5.36B	287.73M	924.18M	2.5229

Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-07	Eingeleitet	Leerink Partners	Outperform
2026-03-24	Hochstufung	H.C. Wainwright	Neutral → Buy
2026-03-24	Hochstufung	Wells Fargo	Equal Weight → Overweight
2026-01-20	Hochstufung	Citizens JMP	Mkt Perform → Mkt Outperform
2025-06-16	Hochstufung	Piper Sandler	Neutral → Overweight
2025-03-17	Herabstufung	H.C. Wainwright	Buy → Neutral
2025-03-14	Herabstufung	BofA Securities	Buy → Underperform
2025-03-14	Herabstufung	Citizens JMP	Mkt Outperform → Mkt Perform
2025-03-14	Herabstufung	Wedbush	Outperform → Neutral
2024-05-08	Eingeleitet	BofA Securities	Buy
2023-11-09	Eingeleitet	Deutsche Bank	Buy
2023-10-06	Eingeleitet	Oppenheimer	Outperform
2023-03-21	Herabstufung	Wells Fargo	Overweight → Equal Weight
2022-08-18	Fortgesetzt	Wells Fargo	Overweight
2021-06-18	Eingeleitet	H.C. Wainwright	Buy
2020-12-03	Eingeleitet	Stifel	Buy
2020-09-02	Eingeleitet	Jefferies	Buy
2020-07-16	Eingeleitet	Wells Fargo	Overweight
2020-01-13	Eingeleitet	SunTrust	Buy
2019-10-07	Eingeleitet	BTIG Research	Buy
2019-07-18	Eingeleitet	Deutsche Bank	Buy
2019-04-29	Eingeleitet	H.C. Wainwright	Buy
2018-10-22	Eingeleitet	JMP Securities	Mkt Outperform
2018-10-22	Eingeleitet	Piper Jaffray	Overweight
2018-10-22	Eingeleitet	Wedbush	Outperform

Alle ansehen

Sutro Biopharma Inc Aktie (STRO) Neueste Nachrichten

May 02, 2026

Sutro Biopharma (NASDAQ:STRO) Upgraded by Mizuho to "Strong-Buy" Rating - MarketBeat

May 01, 2026

Citizens Lifts PT on Sutro Biopharma (STRO) on Its Pipeline and Lead Program - Insider Monkey

May 01, 2026

Mizuho initiates coverage of Sutro Biopharma (STRO) with outperform recommendation - MSN

May 01, 2026

Apr 30, 2026

Sutro Biopharma: Recycling Past Data Ahead Of The Readout, Sell - Seeking Alpha

Apr 30, 2026

MSN Money - MSN

Apr 30, 2026

This Palantir Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday - Benzinga

Apr 30, 2026

Mizuho Securities Initiates Sutro Biopharma(STRO.US) With Buy Rating, Announces Target Price $50 - Moomoo

Apr 30, 2026

Short Interest in Sutro Biopharma, Inc. (NASDAQ:STRO) Grows By 17.0% - MarketBeat

Apr 30, 2026

Mizuho Initiates Sutro Biopharma at Outperform With $50 Price Target - marketscreener.com

Apr 30, 2026

STRO Initiated Coverage by Mizuho -- Rating Set at Outperform - GuruFocus

Apr 30, 2026

Mizuho initiates Sutro Biopharma stock coverage with outperform rating By Investing.com - Investing.com India

Apr 30, 2026

Mizuho initiates Sutro Biopharma stock coverage with outperform rating - Investing.com

Apr 30, 2026

Apr 29, 2026

Sutro Biopharma (NASDAQ:STRO) Hits New 1-Year HighWhat's Next? - MarketBeat

Apr 29, 2026

Sutro Biopharma Strengthens Financial Position and Advances ADC Pipeline - HarianBasis.co

Apr 29, 2026

Here is Why Sutro Biopharma (STRO) is One of the Tiny Stocks That Are On Fire Right Now - Insider Monkey

Apr 29, 2026

5 Tiny Stocks That Are On Fire Right Now - Insider Monkey

Apr 29, 2026

Apr 28, 2026

Sutro Biopharma (NASDAQ:STRO) Shares Up 5.6%What's Next? - MarketBeat

Apr 28, 2026

Apr 27, 2026

Sutro Biopharma (STRO) price target decreased by 21.62% to 29.58 - MSN

Apr 27, 2026

Apr 26, 2026

Sutro Biopharma prices $110M common stock offering - MSN

Apr 26, 2026

Apr 24, 2026